InvestorsHub Logo
Followers 30
Posts 2500
Boards Moderated 0
Alias Born 07/28/2005

Re: torau69 post# 162580

Sunday, 02/23/2014 10:25:49 PM

Sunday, February 23, 2014 10:25:49 PM

Post# of 346056
Torau, the Phase 3 NSCLC trial is underway, with several recruitment centers announced. Thus, it is at the initiation stage. We don't know how many patients, if any, have received dosing yet. PPHM indicated they will be reporting interim trial results, so completion is a relative term that doesn't necessarily align with where investors would consider interim results delivering substance that would translate to pps movement. Perhaps, a biotech savvy poster can suggest when we might anticipate seeing earliest interim results of significance for investors?

Best wishes and IMO,
KT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News